Non-coding RNA has huge potential as next-generation innovative drug targets for the patients with intractable diseases. Our proprietary CRISPR-based technology allows us to identify drug target on non-coding RNA.
CLOVERNA’s mission is to accelerate innovative drug discovery targeting non-coding RNA to treat the patients with difficult-to-treat diseases.